{"entity":{"id":"berry-oncology","kind":"company","name":"Berry Oncology","aka":["Berry Oncology Corporation"],"tldr":"A Beijing cancer genomics company that launched HIFI Pan-Cancer Screening, a whole-genome blood test for six cancers, in 2022.","summary":"Berry Oncology Corporation, whose staff give a Beijing address in their papers, publishes cell-free DNA tests for single cancers (liver, pancreatic, oesophageal, nasopharyngeal) and announced HIFI Pan-Cancer Screening for six cancers on 23 June 2022, with company-reported accuracy figures.","asOf":"2026-11-03","links":[{"label":"Multi-cancer research release (13 October 2021)","url":"https://kyodonewsprwire.jp/release/202110141615"}],"tags":[],"related":[],"cancers":[],"sections":["early-detection","diagnostics"],"technologies":["mced","liquid-biopsy"],"targets":[],"drugs":["hifi-pan-cancer-screening"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Beijing","country":"CN","companyType":"diagnostics","investors":[],"funding":[]},"route":"/companies/berry-oncology/","neighbours":{"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"},{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"}],"technology":[{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"},{"id":"mced","kind":"technology","name":"Multi-cancer early detection (MCED)","route":"/technologies/mced/"}],"drug":[{"id":"hifi-pan-cancer-screening","kind":"drug","name":"HIFI Pan-Cancer Screening (Berry Oncology)","route":"/drugs/hifi-pan-cancer-screening/"}]}}